Experimental Cancer Medicine Centre (ECMC) network proposal for a consensus gene panel for pan-cancer sequencing: a Delphi methodology Article Swipe
Richard Phillips
,
Bristi Basu
,
Zohra Butt
,
Mounia Beloueche
,
Natalie Cook
,
Simon J. Crabb
,
Alastair Greystoke
,
Darren Hargrave
,
Robert Jones
,
Muhammad Yasin Kureeman
,
Juanita Lopez
,
Claire McKeeve
,
Magdalena Meissner
,
Brent O’Carrigan
,
Eileen E. Parkes
,
Milind Ronghe
,
Patricia Roxburgh
,
Debashis Sarker
,
Kienan I. Savage
,
Paul H.S. Shaw
,
Stefan Symeonides
,
Deborah A. Tweddle
,
Aditi Vedi
,
Harriet S. Walter
,
Joanna Zabkiewicz
,
Gary W. Middleton
,
Andrew D. Beggs
·
YOU?
·
· 2025
· Open Access
·
· DOI: https://doi.org/10.1038/s41416-025-03252-6
YOU?
·
· 2025
· Open Access
·
· DOI: https://doi.org/10.1038/s41416-025-03252-6
Background The Experimental Cancer Medicine Centre (ECMC) Network supports UK-wide access to experimental cancer therapies, many of which require specific genomic alterations. This study aimed to develop expert consensus on essential genes for a pan-cancer sequencing panel, involving subject matter experts (SMEs) from the ECMC Network and the pharmaceutical industry. Methods A pilot with 8 SMEs graded 526 genes, refining the list to 210. A three-round Delphi process was then used, with SMEs iteratively evaluating each gene. In the final round, SMEs also assessed the inclusion of tumour mutational burden (TMB), microsatellite instability (MSI), and mutation types (structural variations, copy number variations, and/or fusions). Results Consensus was reached on a final panel of 99 genes applicable across multiple cancers. High agreement was also achieved for including TMB, MSI, and screening for structural variations, copy number variants, and fusions. The panel is intended for both adult and paediatric tumour types. Conclusions This consensus-based gene panel offers a standardised approach to pan-cancer genomic screening. It supports harmonised diagnostics and could improve patient access to personalised therapies and research trials across clinical and NHS settings.
Related Topics
Concepts
Delphi method
Medicine
Delphi
Personalized medicine
Precision medicine
Clinical trial
Medical physics
Genomics
Cancer Medicine
Bioinformatics
Microsatellite instability
Process (computing)
Computer science
Computational biology
Family medicine
MEDLINE
Inclusion (mineral)
Consensus conference
Cancer
DNA sequencing
Cancer genetics
Cancer treatment
Pharmaceutical industry
Data mining
Data science
Genetic testing
Gene nomenclature
Gene regulatory network
Nutrigenomics
Metadata
- Type
- article
- Language
- en
- Landing Page
- https://doi.org/10.1038/s41416-025-03252-6
- https://www.nature.com/articles/s41416-025-03252-6.pdf
- OA Status
- hybrid
- References
- 12
- OpenAlex ID
- https://openalex.org/W7104452573
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W7104452573Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.1038/s41416-025-03252-6Digital Object Identifier
- Title
-
Experimental Cancer Medicine Centre (ECMC) network proposal for a consensus gene panel for pan-cancer sequencing: a Delphi methodologyWork title
- Type
-
articleOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2025Year of publication
- Publication date
-
2025-11-08Full publication date if available
- Authors
-
Richard Phillips, Bristi Basu, Zohra Butt, Mounia Beloueche, Natalie Cook, Simon J. Crabb, Alastair Greystoke, Darren Hargrave, Robert Jones, Muhammad Yasin Kureeman, Juanita Lopez, Claire McKeeve, Magdalena Meissner, Brent O’Carrigan, Eileen E. Parkes, Milind Ronghe, Patricia Roxburgh, Debashis Sarker, Kienan I. Savage, Paul H.S. Shaw, Stefan Symeonides, Deborah A. Tweddle, Aditi Vedi, Harriet S. Walter, Joanna Zabkiewicz, Gary W. Middleton, Andrew D. BeggsList of authors in order
- Landing page
-
https://doi.org/10.1038/s41416-025-03252-6Publisher landing page
- PDF URL
-
https://www.nature.com/articles/s41416-025-03252-6.pdfDirect link to full text PDF
- Open access
-
YesWhether a free full text is available
- OA status
-
hybridOpen access status per OpenAlex
- OA URL
-
https://www.nature.com/articles/s41416-025-03252-6.pdfDirect OA link when available
- Concepts
-
Delphi method, Medicine, Delphi, Personalized medicine, Precision medicine, Clinical trial, Medical physics, Genomics, Cancer Medicine, Bioinformatics, Microsatellite instability, Process (computing), Computer science, Computational biology, Family medicine, MEDLINE, Inclusion (mineral), Consensus conference, Cancer, DNA sequencing, Cancer genetics, Cancer treatment, Pharmaceutical industry, Data mining, Data science, Genetic testing, Gene nomenclature, Gene regulatory network, NutrigenomicsTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
0Total citation count in OpenAlex
- References (count)
-
12Number of works referenced by this work
Full payload
| id | https://openalex.org/W7104452573 |
|---|---|
| doi | https://doi.org/10.1038/s41416-025-03252-6 |
| ids.doi | https://doi.org/10.1038/s41416-025-03252-6 |
| ids.pmid | https://pubmed.ncbi.nlm.nih.gov/41206382 |
| ids.openalex | https://openalex.org/W7104452573 |
| fwci | 0.0 |
| type | article |
| title | Experimental Cancer Medicine Centre (ECMC) network proposal for a consensus gene panel for pan-cancer sequencing: a Delphi methodology |
| biblio.issue | |
| biblio.volume | |
| biblio.last_page | |
| biblio.first_page | |
| topics[0].id | https://openalex.org/T11287 |
| topics[0].field.id | https://openalex.org/fields/13 |
| topics[0].field.display_name | Biochemistry, Genetics and Molecular Biology |
| topics[0].score | 0.5699329972267151 |
| topics[0].domain.id | https://openalex.org/domains/1 |
| topics[0].domain.display_name | Life Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/1306 |
| topics[0].subfield.display_name | Cancer Research |
| topics[0].display_name | Cancer Genomics and Diagnostics |
| topics[1].id | https://openalex.org/T12226 |
| topics[1].field.id | https://openalex.org/fields/27 |
| topics[1].field.display_name | Medicine |
| topics[1].score | 0.0522434301674366 |
| topics[1].domain.id | https://openalex.org/domains/4 |
| topics[1].domain.display_name | Health Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/2728 |
| topics[1].subfield.display_name | Neurology |
| topics[1].display_name | Neuroblastoma Research and Treatments |
| topics[2].id | https://openalex.org/T11642 |
| topics[2].field.id | https://openalex.org/fields/13 |
| topics[2].field.display_name | Biochemistry, Genetics and Molecular Biology |
| topics[2].score | 0.048924047499895096 |
| topics[2].domain.id | https://openalex.org/domains/1 |
| topics[2].domain.display_name | Life Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/1311 |
| topics[2].subfield.display_name | Genetics |
| topics[2].display_name | Genomics and Rare Diseases |
| is_xpac | False |
| apc_list.value | 3790 |
| apc_list.currency | EUR |
| apc_list.value_usd | 4690 |
| apc_paid.value | 3790 |
| apc_paid.currency | EUR |
| apc_paid.value_usd | 4690 |
| concepts[0].id | https://openalex.org/C60641444 |
| concepts[0].level | 2 |
| concepts[0].score | 0.7462592124938965 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q841602 |
| concepts[0].display_name | Delphi method |
| concepts[1].id | https://openalex.org/C71924100 |
| concepts[1].level | 0 |
| concepts[1].score | 0.5408095121383667 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[1].display_name | Medicine |
| concepts[2].id | https://openalex.org/C2779495148 |
| concepts[2].level | 2 |
| concepts[2].score | 0.5330361723899841 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q487378 |
| concepts[2].display_name | Delphi |
| concepts[3].id | https://openalex.org/C32220436 |
| concepts[3].level | 2 |
| concepts[3].score | 0.5325825214385986 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q2072214 |
| concepts[3].display_name | Personalized medicine |
| concepts[4].id | https://openalex.org/C163763905 |
| concepts[4].level | 2 |
| concepts[4].score | 0.49663621187210083 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q17075943 |
| concepts[4].display_name | Precision medicine |
| concepts[5].id | https://openalex.org/C535046627 |
| concepts[5].level | 2 |
| concepts[5].score | 0.39723142981529236 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q30612 |
| concepts[5].display_name | Clinical trial |
| concepts[6].id | https://openalex.org/C19527891 |
| concepts[6].level | 1 |
| concepts[6].score | 0.38811397552490234 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q1120908 |
| concepts[6].display_name | Medical physics |
| concepts[7].id | https://openalex.org/C189206191 |
| concepts[7].level | 4 |
| concepts[7].score | 0.37717968225479126 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q222046 |
| concepts[7].display_name | Genomics |
| concepts[8].id | https://openalex.org/C2776040879 |
| concepts[8].level | 3 |
| concepts[8].score | 0.37423646450042725 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q27724564 |
| concepts[8].display_name | Cancer Medicine |
| concepts[9].id | https://openalex.org/C60644358 |
| concepts[9].level | 1 |
| concepts[9].score | 0.35431572794914246 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q128570 |
| concepts[9].display_name | Bioinformatics |
| concepts[10].id | https://openalex.org/C2779767149 |
| concepts[10].level | 5 |
| concepts[10].score | 0.34260356426239014 |
| concepts[10].wikidata | https://www.wikidata.org/wiki/Q488212 |
| concepts[10].display_name | Microsatellite instability |
| concepts[11].id | https://openalex.org/C98045186 |
| concepts[11].level | 2 |
| concepts[11].score | 0.34025678038597107 |
| concepts[11].wikidata | https://www.wikidata.org/wiki/Q205663 |
| concepts[11].display_name | Process (computing) |
| concepts[12].id | https://openalex.org/C41008148 |
| concepts[12].level | 0 |
| concepts[12].score | 0.33218491077423096 |
| concepts[12].wikidata | https://www.wikidata.org/wiki/Q21198 |
| concepts[12].display_name | Computer science |
| concepts[13].id | https://openalex.org/C70721500 |
| concepts[13].level | 1 |
| concepts[13].score | 0.3290608525276184 |
| concepts[13].wikidata | https://www.wikidata.org/wiki/Q177005 |
| concepts[13].display_name | Computational biology |
| concepts[14].id | https://openalex.org/C512399662 |
| concepts[14].level | 1 |
| concepts[14].score | 0.3246133029460907 |
| concepts[14].wikidata | https://www.wikidata.org/wiki/Q3505712 |
| concepts[14].display_name | Family medicine |
| concepts[15].id | https://openalex.org/C2779473830 |
| concepts[15].level | 2 |
| concepts[15].score | 0.3237435221672058 |
| concepts[15].wikidata | https://www.wikidata.org/wiki/Q1540899 |
| concepts[15].display_name | MEDLINE |
| concepts[16].id | https://openalex.org/C109359841 |
| concepts[16].level | 2 |
| concepts[16].score | 0.31340503692626953 |
| concepts[16].wikidata | https://www.wikidata.org/wiki/Q728944 |
| concepts[16].display_name | Inclusion (mineral) |
| concepts[17].id | https://openalex.org/C3017605391 |
| concepts[17].level | 2 |
| concepts[17].score | 0.31186941266059875 |
| concepts[17].wikidata | https://www.wikidata.org/wiki/Q1021509 |
| concepts[17].display_name | Consensus conference |
| concepts[18].id | https://openalex.org/C121608353 |
| concepts[18].level | 2 |
| concepts[18].score | 0.29968613386154175 |
| concepts[18].wikidata | https://www.wikidata.org/wiki/Q12078 |
| concepts[18].display_name | Cancer |
| concepts[19].id | https://openalex.org/C51679486 |
| concepts[19].level | 3 |
| concepts[19].score | 0.2984319031238556 |
| concepts[19].wikidata | https://www.wikidata.org/wiki/Q380546 |
| concepts[19].display_name | DNA sequencing |
| concepts[20].id | https://openalex.org/C2993935542 |
| concepts[20].level | 3 |
| concepts[20].score | 0.28167933225631714 |
| concepts[20].wikidata | https://www.wikidata.org/wiki/Q7092091 |
| concepts[20].display_name | Cancer genetics |
| concepts[21].id | https://openalex.org/C3019816032 |
| concepts[21].level | 3 |
| concepts[21].score | 0.2766088545322418 |
| concepts[21].wikidata | https://www.wikidata.org/wiki/Q2575340 |
| concepts[21].display_name | Cancer treatment |
| concepts[22].id | https://openalex.org/C2779652045 |
| concepts[22].level | 2 |
| concepts[22].score | 0.2735956311225891 |
| concepts[22].wikidata | https://www.wikidata.org/wiki/Q507443 |
| concepts[22].display_name | Pharmaceutical industry |
| concepts[23].id | https://openalex.org/C124101348 |
| concepts[23].level | 1 |
| concepts[23].score | 0.2731379270553589 |
| concepts[23].wikidata | https://www.wikidata.org/wiki/Q172491 |
| concepts[23].display_name | Data mining |
| concepts[24].id | https://openalex.org/C2522767166 |
| concepts[24].level | 1 |
| concepts[24].score | 0.271905779838562 |
| concepts[24].wikidata | https://www.wikidata.org/wiki/Q2374463 |
| concepts[24].display_name | Data science |
| concepts[25].id | https://openalex.org/C2780673598 |
| concepts[25].level | 2 |
| concepts[25].score | 0.2697038948535919 |
| concepts[25].wikidata | https://www.wikidata.org/wiki/Q285223 |
| concepts[25].display_name | Genetic testing |
| concepts[26].id | https://openalex.org/C62177273 |
| concepts[26].level | 4 |
| concepts[26].score | 0.26333674788475037 |
| concepts[26].wikidata | https://www.wikidata.org/wiki/Q5531556 |
| concepts[26].display_name | Gene nomenclature |
| concepts[27].id | https://openalex.org/C67339327 |
| concepts[27].level | 4 |
| concepts[27].score | 0.2563266456127167 |
| concepts[27].wikidata | https://www.wikidata.org/wiki/Q1502576 |
| concepts[27].display_name | Gene regulatory network |
| concepts[28].id | https://openalex.org/C97633540 |
| concepts[28].level | 3 |
| concepts[28].score | 0.25505760312080383 |
| concepts[28].wikidata | https://www.wikidata.org/wiki/Q4328195 |
| concepts[28].display_name | Nutrigenomics |
| keywords[0].id | https://openalex.org/keywords/delphi-method |
| keywords[0].score | 0.7462592124938965 |
| keywords[0].display_name | Delphi method |
| keywords[1].id | https://openalex.org/keywords/delphi |
| keywords[1].score | 0.5330361723899841 |
| keywords[1].display_name | Delphi |
| keywords[2].id | https://openalex.org/keywords/personalized-medicine |
| keywords[2].score | 0.5325825214385986 |
| keywords[2].display_name | Personalized medicine |
| keywords[3].id | https://openalex.org/keywords/precision-medicine |
| keywords[3].score | 0.49663621187210083 |
| keywords[3].display_name | Precision medicine |
| keywords[4].id | https://openalex.org/keywords/clinical-trial |
| keywords[4].score | 0.39723142981529236 |
| keywords[4].display_name | Clinical trial |
| keywords[5].id | https://openalex.org/keywords/genomics |
| keywords[5].score | 0.37717968225479126 |
| keywords[5].display_name | Genomics |
| keywords[6].id | https://openalex.org/keywords/cancer-medicine |
| keywords[6].score | 0.37423646450042725 |
| keywords[6].display_name | Cancer Medicine |
| keywords[7].id | https://openalex.org/keywords/microsatellite-instability |
| keywords[7].score | 0.34260356426239014 |
| keywords[7].display_name | Microsatellite instability |
| keywords[8].id | https://openalex.org/keywords/process |
| keywords[8].score | 0.34025678038597107 |
| keywords[8].display_name | Process (computing) |
| language | en |
| locations[0].id | doi:10.1038/s41416-025-03252-6 |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S62966998 |
| locations[0].source.issn | 0007-0920, 1532-1827 |
| locations[0].source.type | journal |
| locations[0].source.is_oa | False |
| locations[0].source.issn_l | 0007-0920 |
| locations[0].source.is_core | True |
| locations[0].source.is_in_doaj | False |
| locations[0].source.display_name | British Journal of Cancer |
| locations[0].source.host_organization | https://openalex.org/P4310319965 |
| locations[0].source.host_organization_name | Springer Nature |
| locations[0].source.host_organization_lineage | https://openalex.org/P4310319965 |
| locations[0].license | cc-by |
| locations[0].pdf_url | https://www.nature.com/articles/s41416-025-03252-6.pdf |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | https://openalex.org/licenses/cc-by |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | British Journal of Cancer |
| locations[0].landing_page_url | https://doi.org/10.1038/s41416-025-03252-6 |
| locations[1].id | pmid:41206382 |
| locations[1].is_oa | False |
| locations[1].source.id | https://openalex.org/S4306525036 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | PubMed |
| locations[1].source.host_organization | https://openalex.org/I1299303238 |
| locations[1].source.host_organization_name | National Institutes of Health |
| locations[1].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[1].license | |
| locations[1].pdf_url | |
| locations[1].version | publishedVersion |
| locations[1].raw_type | |
| locations[1].license_id | |
| locations[1].is_accepted | True |
| locations[1].is_published | True |
| locations[1].raw_source_name | British journal of cancer |
| locations[1].landing_page_url | https://pubmed.ncbi.nlm.nih.gov/41206382 |
| indexed_in | crossref, pubmed |
| authorships[0].author.id | https://openalex.org/A1998896300 |
| authorships[0].author.orcid | https://orcid.org/0000-0002-8978-9743 |
| authorships[0].author.display_name | Richard Phillips |
| authorships[0].countries | GB |
| authorships[0].affiliations[0].raw_affiliation_string | Department of Cancer & Genomic Sciences, College of Medicine and Health, University of Birmingham, Birmingham, UK. [email protected]. |
| authorships[0].institutions[0].id | https://openalex.org/I4210135017 |
| authorships[0].institutions[0].ror | https://ror.org/https://ror.org/03qxptw71 |
| authorships[0].institutions[0].type | facility |
| authorships[0].institutions[0].lineage | https://openalex.org/I2801316944, https://openalex.org/I4210135017, https://openalex.org/I79619799 |
| authorships[0].institutions[0].country_code | GB |
| authorships[0].institutions[0].display_name | Cancer Research UK Clinical Trials Unit |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Richard Phillips |
| authorships[0].is_corresponding | True |
| authorships[0].raw_affiliation_strings | Department of Cancer & Genomic Sciences, College of Medicine and Health, University of Birmingham, Birmingham, UK. [email protected]. |
| authorships[1].author.id | https://openalex.org/A2096859358 |
| authorships[1].author.orcid | https://orcid.org/0000-0002-3562-2868 |
| authorships[1].author.display_name | Bristi Basu |
| authorships[1].countries | GB |
| authorships[1].affiliations[0].institution_ids | https://openalex.org/I241749, https://openalex.org/I2802466933 |
| authorships[1].affiliations[0].raw_affiliation_string | University of Cambridge and Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK. |
| authorships[1].institutions[0].id | https://openalex.org/I241749 |
| authorships[1].institutions[0].ror | https://ror.org/https://ror.org/013meh722 |
| authorships[1].institutions[0].type | education |
| authorships[1].institutions[0].lineage | https://openalex.org/I241749 |
| authorships[1].institutions[0].country_code | GB |
| authorships[1].institutions[0].display_name | University of Cambridge |
| authorships[1].institutions[1].id | https://openalex.org/I2802466933 |
| authorships[1].institutions[1].ror | https://ror.org/https://ror.org/04v54gj93 |
| authorships[1].institutions[1].type | funder |
| authorships[1].institutions[1].lineage | https://openalex.org/I2802466933 |
| authorships[1].institutions[1].country_code | GB |
| authorships[1].institutions[1].display_name | Cambridge University Hospitals NHS Foundation Trust |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Bristi Basu |
| authorships[1].is_corresponding | False |
| authorships[1].raw_affiliation_strings | University of Cambridge and Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK. |
| authorships[2].author.id | https://openalex.org/A2226264730 |
| authorships[2].author.orcid | https://orcid.org/0000-0002-8307-9812 |
| authorships[2].author.display_name | Zohra Butt |
| authorships[2].affiliations[0].raw_affiliation_string | Pierre Fabre Ltd, Green Park, Reading, UK. |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Zohra Butt |
| authorships[2].is_corresponding | False |
| authorships[2].raw_affiliation_strings | Pierre Fabre Ltd, Green Park, Reading, UK. |
| authorships[3].author.id | |
| authorships[3].author.orcid | |
| authorships[3].author.display_name | Mounia Beloueche |
| authorships[3].countries | DE |
| authorships[3].affiliations[0].institution_ids | https://openalex.org/I1330995197 |
| authorships[3].affiliations[0].raw_affiliation_string | Boehringer Ingelheim, Ingelheim am Rhein, Germany. |
| authorships[3].institutions[0].id | https://openalex.org/I1330995197 |
| authorships[3].institutions[0].ror | https://ror.org/https://ror.org/00q32j219 |
| authorships[3].institutions[0].type | company |
| authorships[3].institutions[0].lineage | https://openalex.org/I1330995197 |
| authorships[3].institutions[0].country_code | DE |
| authorships[3].institutions[0].display_name | Boehringer Ingelheim (Germany) |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Mounia Beloueche |
| authorships[3].is_corresponding | False |
| authorships[3].raw_affiliation_strings | Boehringer Ingelheim, Ingelheim am Rhein, Germany. |
| authorships[4].author.id | https://openalex.org/A2107007696 |
| authorships[4].author.orcid | https://orcid.org/0000-0003-1556-6739 |
| authorships[4].author.display_name | Natalie Cook |
| authorships[4].affiliations[0].raw_affiliation_string | Experimental Cancer Medicine Team, Christie Hospital NHS Foundation Trust and University of Manchester, Manchester, UK. |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | Natalie Cook |
| authorships[4].is_corresponding | False |
| authorships[4].raw_affiliation_strings | Experimental Cancer Medicine Team, Christie Hospital NHS Foundation Trust and University of Manchester, Manchester, UK. |
| authorships[5].author.id | https://openalex.org/A2101419559 |
| authorships[5].author.orcid | https://orcid.org/0000-0003-3521-9064 |
| authorships[5].author.display_name | Simon J. Crabb |
| authorships[5].affiliations[0].raw_affiliation_string | Southampton ECMC, University of Southampton, Southampton, UK. |
| authorships[5].author_position | middle |
| authorships[5].raw_author_name | Simon J Crabb |
| authorships[5].is_corresponding | False |
| authorships[5].raw_affiliation_strings | Southampton ECMC, University of Southampton, Southampton, UK. |
| authorships[6].author.id | https://openalex.org/A3190051468 |
| authorships[6].author.orcid | https://orcid.org/0000-0001-9168-0387 |
| authorships[6].author.display_name | Alastair Greystoke |
| authorships[6].affiliations[0].raw_affiliation_string | Institute of Clinical and Translational Medicine, Newcastle University, Newcastle upon Tyne, UK. |
| authorships[6].author_position | middle |
| authorships[6].raw_author_name | Alastair Greystoke |
| authorships[6].is_corresponding | False |
| authorships[6].raw_affiliation_strings | Institute of Clinical and Translational Medicine, Newcastle University, Newcastle upon Tyne, UK. |
| authorships[7].author.id | https://openalex.org/A2253954258 |
| authorships[7].author.orcid | https://orcid.org/0000-0001-8219-9807 |
| authorships[7].author.display_name | Darren Hargrave |
| authorships[7].countries | GB |
| authorships[7].affiliations[0].institution_ids | https://openalex.org/I45129253 |
| authorships[7].affiliations[0].raw_affiliation_string | Paediatric Oncology, University College London Institute of Child Health, London, UK. |
| authorships[7].institutions[0].id | https://openalex.org/I45129253 |
| authorships[7].institutions[0].ror | https://ror.org/https://ror.org/02jx3x895 |
| authorships[7].institutions[0].type | education |
| authorships[7].institutions[0].lineage | https://openalex.org/I124357947, https://openalex.org/I45129253 |
| authorships[7].institutions[0].country_code | GB |
| authorships[7].institutions[0].display_name | University College London |
| authorships[7].author_position | middle |
| authorships[7].raw_author_name | Darren Hargrave |
| authorships[7].is_corresponding | False |
| authorships[7].raw_affiliation_strings | Paediatric Oncology, University College London Institute of Child Health, London, UK. |
| authorships[8].author.id | https://openalex.org/A2055371959 |
| authorships[8].author.orcid | https://orcid.org/0000-0001-5608-001X |
| authorships[8].author.display_name | Robert Jones |
| authorships[8].affiliations[0].raw_affiliation_string | Cardiff University and Velindre University NHS Trust, Velindre School of Medicine, Museum Avenue, Cardiff, UK. |
| authorships[8].author_position | middle |
| authorships[8].raw_author_name | Robert Jones |
| authorships[8].is_corresponding | False |
| authorships[8].raw_affiliation_strings | Cardiff University and Velindre University NHS Trust, Velindre School of Medicine, Museum Avenue, Cardiff, UK. |
| authorships[9].author.id | |
| authorships[9].author.orcid | |
| authorships[9].author.display_name | Muhammad Yasin Kureeman |
| authorships[9].affiliations[0].raw_affiliation_string | Pierre Fabre Ltd, Green Park, Reading, UK. |
| authorships[9].author_position | middle |
| authorships[9].raw_author_name | Muhammad Yasin Kureeman |
| authorships[9].is_corresponding | False |
| authorships[9].raw_affiliation_strings | Pierre Fabre Ltd, Green Park, Reading, UK. |
| authorships[10].author.id | https://openalex.org/A2103336546 |
| authorships[10].author.orcid | https://orcid.org/0000-0001-8321-4212 |
| authorships[10].author.display_name | Juanita Lopez |
| authorships[10].affiliations[0].raw_affiliation_string | Drug Development Unit, Royal Marsden NHS Foundation Trust and the Institute of Cancer Research, Oak Cancer Centre, Sutton, UK. |
| authorships[10].author_position | middle |
| authorships[10].raw_author_name | Juanita Lopez |
| authorships[10].is_corresponding | False |
| authorships[10].raw_affiliation_strings | Drug Development Unit, Royal Marsden NHS Foundation Trust and the Institute of Cancer Research, Oak Cancer Centre, Sutton, UK. |
| authorships[11].author.id | https://openalex.org/A3086112537 |
| authorships[11].author.orcid | |
| authorships[11].author.display_name | Claire McKeeve |
| authorships[11].affiliations[0].raw_affiliation_string | West of Scotland Centre for Genomic Medicine, NHS Greater Glasgow and Clyde, Glasgow, UK. |
| authorships[11].author_position | middle |
| authorships[11].raw_author_name | Claire McKeeve |
| authorships[11].is_corresponding | False |
| authorships[11].raw_affiliation_strings | West of Scotland Centre for Genomic Medicine, NHS Greater Glasgow and Clyde, Glasgow, UK. |
| authorships[12].author.id | https://openalex.org/A2530850314 |
| authorships[12].author.orcid | https://orcid.org/0000-0001-5897-0219 |
| authorships[12].author.display_name | Magdalena Meissner |
| authorships[12].affiliations[0].raw_affiliation_string | Cardiff University and Velindre University NHS Trust, Velindre School of Medicine, Museum Avenue, Cardiff, UK. |
| authorships[12].author_position | middle |
| authorships[12].raw_author_name | Magdalena Meissner |
| authorships[12].is_corresponding | False |
| authorships[12].raw_affiliation_strings | Cardiff University and Velindre University NHS Trust, Velindre School of Medicine, Museum Avenue, Cardiff, UK. |
| authorships[13].author.id | https://openalex.org/A4282894817 |
| authorships[13].author.orcid | https://orcid.org/0000-0001-8187-6298 |
| authorships[13].author.display_name | Brent O’Carrigan |
| authorships[13].countries | GB |
| authorships[13].affiliations[0].institution_ids | https://openalex.org/I241749, https://openalex.org/I2802466933 |
| authorships[13].affiliations[0].raw_affiliation_string | University of Cambridge and Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK. |
| authorships[13].institutions[0].id | https://openalex.org/I2802466933 |
| authorships[13].institutions[0].ror | https://ror.org/https://ror.org/04v54gj93 |
| authorships[13].institutions[0].type | funder |
| authorships[13].institutions[0].lineage | https://openalex.org/I2802466933 |
| authorships[13].institutions[0].country_code | GB |
| authorships[13].institutions[0].display_name | Cambridge University Hospitals NHS Foundation Trust |
| authorships[13].institutions[1].id | https://openalex.org/I241749 |
| authorships[13].institutions[1].ror | https://ror.org/https://ror.org/013meh722 |
| authorships[13].institutions[1].type | education |
| authorships[13].institutions[1].lineage | https://openalex.org/I241749 |
| authorships[13].institutions[1].country_code | GB |
| authorships[13].institutions[1].display_name | University of Cambridge |
| authorships[13].author_position | middle |
| authorships[13].raw_author_name | Brent O'Carrigan |
| authorships[13].is_corresponding | False |
| authorships[13].raw_affiliation_strings | University of Cambridge and Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK. |
| authorships[14].author.id | https://openalex.org/A4209984918 |
| authorships[14].author.orcid | https://orcid.org/0000-0002-7855-3698 |
| authorships[14].author.display_name | Eileen E. Parkes |
| authorships[14].countries | GB |
| authorships[14].affiliations[0].institution_ids | https://openalex.org/I40120149 |
| authorships[14].affiliations[0].raw_affiliation_string | Department of Oncology, University of Oxford, Oxford, UK. |
| authorships[14].institutions[0].id | https://openalex.org/I40120149 |
| authorships[14].institutions[0].ror | https://ror.org/https://ror.org/052gg0110 |
| authorships[14].institutions[0].type | education |
| authorships[14].institutions[0].lineage | https://openalex.org/I40120149 |
| authorships[14].institutions[0].country_code | GB |
| authorships[14].institutions[0].display_name | University of Oxford |
| authorships[14].author_position | middle |
| authorships[14].raw_author_name | Eileen E Parkes |
| authorships[14].is_corresponding | False |
| authorships[14].raw_affiliation_strings | Department of Oncology, University of Oxford, Oxford, UK. |
| authorships[15].author.id | https://openalex.org/A2137542498 |
| authorships[15].author.orcid | https://orcid.org/0000-0002-1865-9335 |
| authorships[15].author.display_name | Milind Ronghe |
| authorships[15].affiliations[0].raw_affiliation_string | Paediatric Oncology Department, Royal Hospital for Children, Glasgow, UK. |
| authorships[15].author_position | middle |
| authorships[15].raw_author_name | Milind Ronghe |
| authorships[15].is_corresponding | False |
| authorships[15].raw_affiliation_strings | Paediatric Oncology Department, Royal Hospital for Children, Glasgow, UK. |
| authorships[16].author.id | https://openalex.org/A1828501907 |
| authorships[16].author.orcid | https://orcid.org/0000-0001-9869-591X |
| authorships[16].author.display_name | Patricia Roxburgh |
| authorships[16].countries | GB |
| authorships[16].affiliations[0].institution_ids | https://openalex.org/I7882870 |
| authorships[16].affiliations[0].raw_affiliation_string | School of Cancer Sciences, Wolfson Wohl Cancer Research Centre, University of Glasgow, Glasgow, UK. |
| authorships[16].institutions[0].id | https://openalex.org/I7882870 |
| authorships[16].institutions[0].ror | https://ror.org/https://ror.org/00vtgdb53 |
| authorships[16].institutions[0].type | education |
| authorships[16].institutions[0].lineage | https://openalex.org/I7882870 |
| authorships[16].institutions[0].country_code | GB |
| authorships[16].institutions[0].display_name | University of Glasgow |
| authorships[16].author_position | middle |
| authorships[16].raw_author_name | Patricia Roxburgh |
| authorships[16].is_corresponding | False |
| authorships[16].raw_affiliation_strings | School of Cancer Sciences, Wolfson Wohl Cancer Research Centre, University of Glasgow, Glasgow, UK. |
| authorships[17].author.id | https://openalex.org/A2426472429 |
| authorships[17].author.orcid | https://orcid.org/0000-0001-6948-2974 |
| authorships[17].author.display_name | Debashis Sarker |
| authorships[17].countries | GB |
| authorships[17].affiliations[0].institution_ids | https://openalex.org/I183935753 |
| authorships[17].affiliations[0].raw_affiliation_string | School of Cancer and Pharmaceutical Sciences, King's College London, London, UK. |
| authorships[17].institutions[0].id | https://openalex.org/I183935753 |
| authorships[17].institutions[0].ror | https://ror.org/https://ror.org/0220mzb33 |
| authorships[17].institutions[0].type | education |
| authorships[17].institutions[0].lineage | https://openalex.org/I124357947, https://openalex.org/I183935753 |
| authorships[17].institutions[0].country_code | GB |
| authorships[17].institutions[0].display_name | King's College London |
| authorships[17].author_position | middle |
| authorships[17].raw_author_name | Debashis Sarker |
| authorships[17].is_corresponding | False |
| authorships[17].raw_affiliation_strings | School of Cancer and Pharmaceutical Sciences, King's College London, London, UK. |
| authorships[18].author.id | https://openalex.org/A2166393413 |
| authorships[18].author.orcid | https://orcid.org/0000-0002-4898-899X |
| authorships[18].author.display_name | Kienan I. Savage |
| authorships[18].countries | GB |
| authorships[18].affiliations[0].institution_ids | https://openalex.org/I126231945 |
| authorships[18].affiliations[0].raw_affiliation_string | Patrick G Johnston Centre for Cancer Research, Queen's University Belfast, Belfast, UK. |
| authorships[18].institutions[0].id | https://openalex.org/I126231945 |
| authorships[18].institutions[0].ror | https://ror.org/https://ror.org/00hswnk62 |
| authorships[18].institutions[0].type | education |
| authorships[18].institutions[0].lineage | https://openalex.org/I126231945 |
| authorships[18].institutions[0].country_code | GB |
| authorships[18].institutions[0].display_name | Queen's University Belfast |
| authorships[18].author_position | middle |
| authorships[18].raw_author_name | Kienan I Savage |
| authorships[18].is_corresponding | False |
| authorships[18].raw_affiliation_strings | Patrick G Johnston Centre for Cancer Research, Queen's University Belfast, Belfast, UK. |
| authorships[19].author.id | https://openalex.org/A2308710251 |
| authorships[19].author.orcid | |
| authorships[19].author.display_name | Paul H.S. Shaw |
| authorships[19].countries | GB |
| authorships[19].affiliations[0].raw_affiliation_string | Department of Clinical Oncology, Velindre University NHS Trust, Cardiff, UK. |
| authorships[19].institutions[0].id | https://openalex.org/I2799279586 |
| authorships[19].institutions[0].ror | https://ror.org/https://ror.org/05ntqkc30 |
| authorships[19].institutions[0].type | healthcare |
| authorships[19].institutions[0].lineage | https://openalex.org/I2799279586 |
| authorships[19].institutions[0].country_code | GB |
| authorships[19].institutions[0].display_name | Velindre NHS Trust |
| authorships[19].author_position | middle |
| authorships[19].raw_author_name | Paul H S Shaw |
| authorships[19].is_corresponding | False |
| authorships[19].raw_affiliation_strings | Department of Clinical Oncology, Velindre University NHS Trust, Cardiff, UK. |
| authorships[20].author.id | https://openalex.org/A1979643811 |
| authorships[20].author.orcid | |
| authorships[20].author.display_name | Stefan Symeonides |
| authorships[20].affiliations[0].raw_affiliation_string | Edinburgh Experimental Cancer Medicine Centre, Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, UK. |
| authorships[20].author_position | middle |
| authorships[20].raw_author_name | Stefan Symeonides |
| authorships[20].is_corresponding | False |
| authorships[20].raw_affiliation_strings | Edinburgh Experimental Cancer Medicine Centre, Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, UK. |
| authorships[21].author.id | https://openalex.org/A626241363 |
| authorships[21].author.orcid | https://orcid.org/0000-0003-2208-3970 |
| authorships[21].author.display_name | Deborah A. Tweddle |
| authorships[21].affiliations[0].raw_affiliation_string | Institute of Clinical and Translational Medicine, Newcastle University, Newcastle upon Tyne, UK. |
| authorships[21].author_position | middle |
| authorships[21].raw_author_name | Deborah A Tweddle |
| authorships[21].is_corresponding | False |
| authorships[21].raw_affiliation_strings | Institute of Clinical and Translational Medicine, Newcastle University, Newcastle upon Tyne, UK. |
| authorships[22].author.id | https://openalex.org/A1992768290 |
| authorships[22].author.orcid | https://orcid.org/0000-0001-6761-6510 |
| authorships[22].author.display_name | Aditi Vedi |
| authorships[22].countries | GB |
| authorships[22].affiliations[0].institution_ids | https://openalex.org/I241749, https://openalex.org/I2802466933 |
| authorships[22].affiliations[0].raw_affiliation_string | University of Cambridge and Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK. |
| authorships[22].institutions[0].id | https://openalex.org/I241749 |
| authorships[22].institutions[0].ror | https://ror.org/https://ror.org/013meh722 |
| authorships[22].institutions[0].type | education |
| authorships[22].institutions[0].lineage | https://openalex.org/I241749 |
| authorships[22].institutions[0].country_code | GB |
| authorships[22].institutions[0].display_name | University of Cambridge |
| authorships[22].institutions[1].id | https://openalex.org/I2802466933 |
| authorships[22].institutions[1].ror | https://ror.org/https://ror.org/04v54gj93 |
| authorships[22].institutions[1].type | funder |
| authorships[22].institutions[1].lineage | https://openalex.org/I2802466933 |
| authorships[22].institutions[1].country_code | GB |
| authorships[22].institutions[1].display_name | Cambridge University Hospitals NHS Foundation Trust |
| authorships[22].author_position | middle |
| authorships[22].raw_author_name | Aditi Vedi |
| authorships[22].is_corresponding | False |
| authorships[22].raw_affiliation_strings | University of Cambridge and Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK. |
| authorships[23].author.id | https://openalex.org/A2232822863 |
| authorships[23].author.orcid | https://orcid.org/0000-0003-2618-711X |
| authorships[23].author.display_name | Harriet S. Walter |
| authorships[23].countries | GB |
| authorships[23].affiliations[0].institution_ids | https://openalex.org/I2802445252 |
| authorships[23].affiliations[0].raw_affiliation_string | University Hospitals of Leicester NHS Trust, Leicester, UK. |
| authorships[23].institutions[0].id | https://openalex.org/I2802445252 |
| authorships[23].institutions[0].ror | https://ror.org/https://ror.org/02fha3693 |
| authorships[23].institutions[0].type | healthcare |
| authorships[23].institutions[0].lineage | https://openalex.org/I2802445252 |
| authorships[23].institutions[0].country_code | GB |
| authorships[23].institutions[0].display_name | University Hospitals of Leicester NHS Trust |
| authorships[23].author_position | middle |
| authorships[23].raw_author_name | Harriet S Walter |
| authorships[23].is_corresponding | False |
| authorships[23].raw_affiliation_strings | University Hospitals of Leicester NHS Trust, Leicester, UK. |
| authorships[24].author.id | https://openalex.org/A2107704328 |
| authorships[24].author.orcid | |
| authorships[24].author.display_name | Joanna Zabkiewicz |
| authorships[24].affiliations[0].raw_affiliation_string | Department of Haematology, School of Medicine, Cardiff University, Heath Hospital, Cardiff, UK. |
| authorships[24].author_position | middle |
| authorships[24].raw_author_name | Joanna Zabkiewicz |
| authorships[24].is_corresponding | False |
| authorships[24].raw_affiliation_strings | Department of Haematology, School of Medicine, Cardiff University, Heath Hospital, Cardiff, UK. |
| authorships[25].author.id | https://openalex.org/A4275828639 |
| authorships[25].author.orcid | |
| authorships[25].author.display_name | Gary W. Middleton |
| authorships[25].countries | GB |
| authorships[25].affiliations[0].raw_affiliation_string | Department of Cancer & Genomic Sciences, College of Medicine and Health, University of Birmingham, Birmingham, UK. |
| authorships[25].institutions[0].id | https://openalex.org/I4210135017 |
| authorships[25].institutions[0].ror | https://ror.org/https://ror.org/03qxptw71 |
| authorships[25].institutions[0].type | facility |
| authorships[25].institutions[0].lineage | https://openalex.org/I2801316944, https://openalex.org/I4210135017, https://openalex.org/I79619799 |
| authorships[25].institutions[0].country_code | GB |
| authorships[25].institutions[0].display_name | Cancer Research UK Clinical Trials Unit |
| authorships[25].author_position | middle |
| authorships[25].raw_author_name | Gary W Middleton |
| authorships[25].is_corresponding | False |
| authorships[25].raw_affiliation_strings | Department of Cancer & Genomic Sciences, College of Medicine and Health, University of Birmingham, Birmingham, UK. |
| authorships[26].author.id | https://openalex.org/A2102792531 |
| authorships[26].author.orcid | https://orcid.org/0000-0003-0784-2967 |
| authorships[26].author.display_name | Andrew D. Beggs |
| authorships[26].countries | GB |
| authorships[26].affiliations[0].raw_affiliation_string | Department of Cancer & Genomic Sciences, College of Medicine and Health, University of Birmingham, Birmingham, UK. |
| authorships[26].institutions[0].id | https://openalex.org/I4210135017 |
| authorships[26].institutions[0].ror | https://ror.org/https://ror.org/03qxptw71 |
| authorships[26].institutions[0].type | facility |
| authorships[26].institutions[0].lineage | https://openalex.org/I2801316944, https://openalex.org/I4210135017, https://openalex.org/I79619799 |
| authorships[26].institutions[0].country_code | GB |
| authorships[26].institutions[0].display_name | Cancer Research UK Clinical Trials Unit |
| authorships[26].author_position | last |
| authorships[26].raw_author_name | Andrew D Beggs |
| authorships[26].is_corresponding | False |
| authorships[26].raw_affiliation_strings | Department of Cancer & Genomic Sciences, College of Medicine and Health, University of Birmingham, Birmingham, UK. |
| has_content.pdf | True |
| has_content.grobid_xml | False |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://www.nature.com/articles/s41416-025-03252-6.pdf |
| open_access.oa_status | hybrid |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-11-09T00:00:00 |
| display_name | Experimental Cancer Medicine Centre (ECMC) network proposal for a consensus gene panel for pan-cancer sequencing: a Delphi methodology |
| has_fulltext | False |
| is_retracted | False |
| updated_date | 2025-11-09T23:12:50.468023 |
| primary_topic.id | https://openalex.org/T11287 |
| primary_topic.field.id | https://openalex.org/fields/13 |
| primary_topic.field.display_name | Biochemistry, Genetics and Molecular Biology |
| primary_topic.score | 0.5699329972267151 |
| primary_topic.domain.id | https://openalex.org/domains/1 |
| primary_topic.domain.display_name | Life Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/1306 |
| primary_topic.subfield.display_name | Cancer Research |
| primary_topic.display_name | Cancer Genomics and Diagnostics |
| cited_by_count | 0 |
| locations_count | 2 |
| best_oa_location.id | doi:10.1038/s41416-025-03252-6 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S62966998 |
| best_oa_location.source.issn | 0007-0920, 1532-1827 |
| best_oa_location.source.type | journal |
| best_oa_location.source.is_oa | False |
| best_oa_location.source.issn_l | 0007-0920 |
| best_oa_location.source.is_core | True |
| best_oa_location.source.is_in_doaj | False |
| best_oa_location.source.display_name | British Journal of Cancer |
| best_oa_location.source.host_organization | https://openalex.org/P4310319965 |
| best_oa_location.source.host_organization_name | Springer Nature |
| best_oa_location.source.host_organization_lineage | https://openalex.org/P4310319965 |
| best_oa_location.license | cc-by |
| best_oa_location.pdf_url | https://www.nature.com/articles/s41416-025-03252-6.pdf |
| best_oa_location.version | publishedVersion |
| best_oa_location.raw_type | journal-article |
| best_oa_location.license_id | https://openalex.org/licenses/cc-by |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | True |
| best_oa_location.raw_source_name | British Journal of Cancer |
| best_oa_location.landing_page_url | https://doi.org/10.1038/s41416-025-03252-6 |
| primary_location.id | doi:10.1038/s41416-025-03252-6 |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S62966998 |
| primary_location.source.issn | 0007-0920, 1532-1827 |
| primary_location.source.type | journal |
| primary_location.source.is_oa | False |
| primary_location.source.issn_l | 0007-0920 |
| primary_location.source.is_core | True |
| primary_location.source.is_in_doaj | False |
| primary_location.source.display_name | British Journal of Cancer |
| primary_location.source.host_organization | https://openalex.org/P4310319965 |
| primary_location.source.host_organization_name | Springer Nature |
| primary_location.source.host_organization_lineage | https://openalex.org/P4310319965 |
| primary_location.license | cc-by |
| primary_location.pdf_url | https://www.nature.com/articles/s41416-025-03252-6.pdf |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | https://openalex.org/licenses/cc-by |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | British Journal of Cancer |
| primary_location.landing_page_url | https://doi.org/10.1038/s41416-025-03252-6 |
| publication_date | 2025-11-08 |
| publication_year | 2025 |
| referenced_works | https://openalex.org/W3043661890, https://openalex.org/W2790254562, https://openalex.org/W4390718808, https://openalex.org/W223909586, https://openalex.org/W4361219294, https://openalex.org/W3054433483, https://openalex.org/W3159639089, https://openalex.org/W4224112809, https://openalex.org/W4224223374, https://openalex.org/W4297473714, https://openalex.org/W3011051319, https://openalex.org/W4409390752 |
| referenced_works_count | 12 |
| abstract_inverted_index.8 | 55 |
| abstract_inverted_index.A | 52, 65 |
| abstract_inverted_index.a | 34, 110, 156 |
| abstract_inverted_index.99 | 114 |
| abstract_inverted_index.In | 78 |
| abstract_inverted_index.It | 163 |
| abstract_inverted_index.is | 141 |
| abstract_inverted_index.of | 17, 87, 113 |
| abstract_inverted_index.on | 30, 109 |
| abstract_inverted_index.to | 12, 26, 63, 159, 172 |
| abstract_inverted_index.526 | 58 |
| abstract_inverted_index.NHS | 181 |
| abstract_inverted_index.The | 2, 139 |
| abstract_inverted_index.and | 47, 95, 129, 137, 146, 167, 175, 180 |
| abstract_inverted_index.for | 33, 125, 131, 143 |
| abstract_inverted_index.the | 44, 48, 61, 79, 85 |
| abstract_inverted_index.was | 69, 107, 122 |
| abstract_inverted_index.210. | 64 |
| abstract_inverted_index.ECMC | 45 |
| abstract_inverted_index.High | 120 |
| abstract_inverted_index.MSI, | 128 |
| abstract_inverted_index.SMEs | 56, 73, 82 |
| abstract_inverted_index.TMB, | 127 |
| abstract_inverted_index.This | 23, 151 |
| abstract_inverted_index.also | 83, 123 |
| abstract_inverted_index.both | 144 |
| abstract_inverted_index.copy | 100, 134 |
| abstract_inverted_index.each | 76 |
| abstract_inverted_index.from | 43 |
| abstract_inverted_index.gene | 153 |
| abstract_inverted_index.list | 62 |
| abstract_inverted_index.many | 16 |
| abstract_inverted_index.then | 70 |
| abstract_inverted_index.with | 54, 72 |
| abstract_inverted_index.adult | 145 |
| abstract_inverted_index.aimed | 25 |
| abstract_inverted_index.could | 168 |
| abstract_inverted_index.final | 80, 111 |
| abstract_inverted_index.gene. | 77 |
| abstract_inverted_index.genes | 32, 115 |
| abstract_inverted_index.panel | 112, 140, 154 |
| abstract_inverted_index.pilot | 53 |
| abstract_inverted_index.study | 24 |
| abstract_inverted_index.types | 97 |
| abstract_inverted_index.used, | 71 |
| abstract_inverted_index.which | 18 |
| abstract_inverted_index.(ECMC) | 7 |
| abstract_inverted_index.(MSI), | 94 |
| abstract_inverted_index.(SMEs) | 42 |
| abstract_inverted_index.(TMB), | 91 |
| abstract_inverted_index.Cancer | 4 |
| abstract_inverted_index.Centre | 6 |
| abstract_inverted_index.Delphi | 67 |
| abstract_inverted_index.access | 11, 171 |
| abstract_inverted_index.across | 117, 178 |
| abstract_inverted_index.and/or | 103 |
| abstract_inverted_index.burden | 90 |
| abstract_inverted_index.cancer | 14 |
| abstract_inverted_index.expert | 28 |
| abstract_inverted_index.genes, | 59 |
| abstract_inverted_index.graded | 57 |
| abstract_inverted_index.matter | 40 |
| abstract_inverted_index.number | 101, 135 |
| abstract_inverted_index.offers | 155 |
| abstract_inverted_index.panel, | 37 |
| abstract_inverted_index.round, | 81 |
| abstract_inverted_index.trials | 177 |
| abstract_inverted_index.tumour | 88, 148 |
| abstract_inverted_index.types. | 149 |
| abstract_inverted_index.Methods | 51 |
| abstract_inverted_index.Network | 8, 46 |
| abstract_inverted_index.Results | 105 |
| abstract_inverted_index.UK-wide | 10 |
| abstract_inverted_index.develop | 27 |
| abstract_inverted_index.experts | 41 |
| abstract_inverted_index.genomic | 21, 161 |
| abstract_inverted_index.improve | 169 |
| abstract_inverted_index.patient | 170 |
| abstract_inverted_index.process | 68 |
| abstract_inverted_index.reached | 108 |
| abstract_inverted_index.require | 19 |
| abstract_inverted_index.subject | 39 |
| abstract_inverted_index.Abstract | 0 |
| abstract_inverted_index.Medicine | 5 |
| abstract_inverted_index.achieved | 124 |
| abstract_inverted_index.approach | 158 |
| abstract_inverted_index.assessed | 84 |
| abstract_inverted_index.cancers. | 119 |
| abstract_inverted_index.clinical | 179 |
| abstract_inverted_index.fusions. | 138 |
| abstract_inverted_index.intended | 142 |
| abstract_inverted_index.multiple | 118 |
| abstract_inverted_index.mutation | 96 |
| abstract_inverted_index.refining | 60 |
| abstract_inverted_index.research | 176 |
| abstract_inverted_index.specific | 20 |
| abstract_inverted_index.supports | 9, 164 |
| abstract_inverted_index.Consensus | 106 |
| abstract_inverted_index.agreement | 121 |
| abstract_inverted_index.consensus | 29 |
| abstract_inverted_index.essential | 31 |
| abstract_inverted_index.fusions). | 104 |
| abstract_inverted_index.including | 126 |
| abstract_inverted_index.inclusion | 86 |
| abstract_inverted_index.industry. | 50 |
| abstract_inverted_index.involving | 38 |
| abstract_inverted_index.screening | 130 |
| abstract_inverted_index.settings. | 182 |
| abstract_inverted_index.therapies | 174 |
| abstract_inverted_index.variants, | 136 |
| abstract_inverted_index.Background | 1 |
| abstract_inverted_index.applicable | 116 |
| abstract_inverted_index.evaluating | 75 |
| abstract_inverted_index.harmonised | 165 |
| abstract_inverted_index.mutational | 89 |
| abstract_inverted_index.paediatric | 147 |
| abstract_inverted_index.pan-cancer | 35, 160 |
| abstract_inverted_index.screening. | 162 |
| abstract_inverted_index.sequencing | 36 |
| abstract_inverted_index.structural | 132 |
| abstract_inverted_index.therapies, | 15 |
| abstract_inverted_index.(structural | 98 |
| abstract_inverted_index.Conclusions | 150 |
| abstract_inverted_index.diagnostics | 166 |
| abstract_inverted_index.instability | 93 |
| abstract_inverted_index.iteratively | 74 |
| abstract_inverted_index.three-round | 66 |
| abstract_inverted_index.variations, | 99, 102, 133 |
| abstract_inverted_index.Experimental | 3 |
| abstract_inverted_index.alterations. | 22 |
| abstract_inverted_index.experimental | 13 |
| abstract_inverted_index.personalised | 173 |
| abstract_inverted_index.standardised | 157 |
| abstract_inverted_index.microsatellite | 92 |
| abstract_inverted_index.pharmaceutical | 49 |
| abstract_inverted_index.consensus-based | 152 |
| cited_by_percentile_year | |
| countries_distinct_count | 2 |
| institutions_distinct_count | 27 |
| citation_normalized_percentile.value | 0.75871625 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | False |